Windfall Bio, a company specializing in methane-to-value solutions, has expanded its research and development capabilities with the opening of a new facility in San Mateo, California. This state-of-the-art facility will serve as Windfall’s R&D hub for evaluating and optimizing operating conditions for on-site pilot deployments of its nature-based solution across various applications.
Methane is a potent greenhouse gas that can be both harmful and valuable. Windfall’s nature-based solution harnesses methane-eating microbes to capture and transform methane emissions from any source into valuable outputs. The company’s solution can create value in various forms, including nitrogen-rich fertilizer, emissions reductions, improved resource efficiency, increased soil health, and new revenue streams for customers with wasted methane resources.
The new facility and growing team enable Windfall to refine its innovative solution for specific application use cases and meet the needs of each customer industry. The learnings and data collected from expanded R&D work will be incorporated into in-field pilot deployments on the company’s path to commercialization.
Recent funding milestones include a $28 million Series A round led by Prelude Ventures with participation from Amazon’s Climate Pledge Fund and others. This funding brings the company’s total fundraising amount to $37 million.
